Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) in the 120-Week Extension to the CLARITY Study

Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Peter Rieckmann, Kottil Rammohan, Per Soelberg-Soerensen, Patrick Vermersch, Emily Martin, Fernando Dangond